tailieuchung - Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRDguided treatment

Đang chuẩn bị liên kết để tải về tài liệu:
Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRDguided treatment

Thu Ngọc 95 8 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

Pediatric acute myeloid leukemia (AML) with t(8;21) (q22;q22) is classified as a low-risk group. However, relapse is still the main factor affecting survival. | Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t 8 21 acute myeloid leukemia in first remission based on MRDguided treatment

Đang chuẩn bị liên kết để tải về tài liệu:
Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRDguided treatment

Wilms’ tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation

Early transplantation-related mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia

Successful allogeneic peripheral blood stem cell transplantation for an aggressive variant of T-cell large granular-lymphocyte leukemia: A case report

Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRDguided treatment

Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): Study protocol for a phase II study

“Safety and utility of percutaneous liver biopsy in hematopoietic stem cell transplant pediatric recipients: A retrospective study”

Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders

Recent advances and current challenges in allogeneic stem cell transplantation in patients with acquired severe aplastic anemia

Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome

Báo cáo y học: "Frequency analysis of TRBV subfamily sjTRECs to characterize T-cell reconstitution in acute leukemia patients after allogeneic hematopoietic stem cell transplantation"

Đang chuẩn bị liên kết để tải về tài liệu: Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRDguided treatment